South Korean health tech company Neurophet has obtained certification from Singapore's Health Sciences Authority for its AI-enabled degenerative brain disease diagnosis assistant software.
Its flagship software, Neurophet Aqua, analyses brain MRI using AI to check for brain atrophy and white matter degeneration as seen in neurodegenerative diseases such as Alzheimer's disease and vascular...
Qure.ai is the latest technology partner to join Medtronic's initiative in advancing stroke care management in India.
According to a press statement, their partnership aims to provide AI solutions to comprehensive stroke centres and primary stroke centres. They also seek to establish a hub-and-spoke network that will assist in faster identification, decision-making, and triaging of stroke...
Indian medical device startup Dozee has raised $6 million in a Series A2 funding round, which was joined by its existing investors – Prime Venture Partners, 3one4 Capital, YourNest VC – and new investors, including State Bank of India, J&A Partners Family, and Dinesh Mody Ventures.
The company develops contactless remote patient monitoring and AI-based early warning system solutions. Its US...
Sydney-based SimConverse has collected A$1.5 million (around $987,000) in a seed funding round led by Folklore Ventures, with participation from Artesian.
WHAT IT DOES
Founded in 2020, SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty for healthcare communications training. It is made to be adaptable and customisable to suit the...
Sixty percent of respondents said they would feel uncomfortable if their healthcare provider relied on AI to diagnose and treat them, according to a survey conducted by the Pew Research Center.
The 2022 survey, which included responses from more than 11,000 U.S. adults, found that 66% of women said they would feel uncomfortable if their provider relied on AI for their medical care, while 54% of...
Vietnamese healthcare AI developer VinBrain has started a new partnership with Stanford University to enhance AI medical imaging.
Based on their latest data use agreement, Stanford will initially provide VinBrain access to about 240,000 anonymised medical images and reports to train and test the AI on its DrAid clinical decision support platform while also helping improve the accuracy of an...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
Researchers from the Commonwealth Scientific and Industrial Research Organisation, in partnership with the Queensland University of Technology, have developed what could be the world's first AI-based benchmark for measuring brain atrophy.
WHAT IT'S ABOUT
They used AI to develop a set of artificial MRI brain images with predefined signs of neurodegeneration in the cortex region, an area of the...
NERVTEX, a Chinese company focused on developing digital therapeutics for brain disorders, has obtained the approval of the China National Medical Products Administration for its AI-powered movement disorder analysis software.
Called MoDAS (Movement Dysfunction Assessment Software), the software as a medical device uses computer vision and deep learning to analyse videos of a patient's movement...
South Korean AI company Lunit has tied up with its investor, Guardant Health, for AI integration.
Under the partnership, Lunit will integrate its PD-L1 scoring algorithm into Guardant's cancer biomarker detection workflow in the Guardant360 TissueNextTM PD-L1 test for non-small cell lung cancer (NSCLC).
Lunit SCOPE PD-L1, a CE-marked AI solution, detects and analyses PD-L1, a type of cancer...
